Clinical Trial Update: Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide [Phase 2]

View source ↗

Summary

A Phase 2 study comparing docetaxel versus cabazitaxel in patients with metastatic prostate cancer after progression on abiraterone or enzalutamide was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cabazitaxel (Jevtana) (cabazitaxel)
• Docetaxel (Taxotere) (docetaxel)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: TERMINATED